Bryhali (halobetasol propionate)

pCPA File Number: 21910

Negotiation Status:

Concluded with an LOI

Indication(s):

corticosteroid-responsive dermatoses and the topical treatment of plaque psoriasis

Sponsor/Manufacturer:

Bausch Health, Canada Inc.

CADTH Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2022-07-13

Negotiation Process Concluded:

2022-09-27